OpenVSafe by OpenVAERS
Search V-safe

D3T-21024-02426

3 vaccinations 7 coded responses 25 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
923 / CA
Registered
2021-03-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Registered in v-safe
  2. 2021-03-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-17
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-03-25
    Health check-in — day 7, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-03-31
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-07
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Adult check-in
  14. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  15. 2021-04-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pain — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Worsening of chronic pain & muscle pain & spasms especially in legs & neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Muscle spasms, Pain, Pre-existing disease — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Pain level and spasms have stayed worse than ususl
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-14
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-04-21
    Survey response — day 14, dose 2
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: At least daily Headaches, with both pain level and duration worsening. On two occasions I have had more than one headache in a 24 hr period.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-29
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-05-06
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-05-13
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-20
    Survey response — day 42, dose 2
    MedDRA: Urinary tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: UTI, onset 5/17.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-20
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-07
    Survey response — 3 months, dose 2
    MedDRA: Muscle spasms, Myalgia — Feeling: Fair
    Free text: Intermittent muscle cramps upper and lower extremities. Cramps are painful.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-10-07
    Survey response — 6 months, dose 2
    MedDRA: Adverse reaction, Sinusitis — Feeling: Good
    Free text: Sinusitis and increased allergy symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-24
    Dose 3 — Pfizer-BioNTech
  29. 2022-04-08
    Survey response — 12 months, dose 2
    MedDRA: Localised infection, Peripheral swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Possible Pneumonia L Lung, Possible Partially collapsed R Lung under the R Diaphragm L Lower leg infection and significant Swelling/ Triple Antibiotics required
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-04-08
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  31. 2022-04-12
  32. 2022-05-28
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Pfizer-BioNTech
22021-04-07Pfizer-BioNTech
32021-11-24Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-10

Systemic reaction (other): Worsening of chronic pain & muscle pain & spasms especially in legs & neck

2021-04-11

Systemic reaction (other): Pain level and spasms have stayed worse than ususl

Release 7 — day 14, dose 2

2021-04-21

Symptoms: At least daily Headaches, with both pain level and duration worsening. On two occasions I have had more than one headache in a 24 hr period.

Release 8 — day 42, dose 2

2021-05-20

Symptoms: UTI, onset 5/17.

Release 9 — 3 months, dose 2

2021-07-07

Symptoms: Intermittent muscle cramps upper and lower extremities. Cramps are painful.

Release 10 — 6 months, dose 2

2021-10-07

Symptoms: Sinusitis and increased allergy symptoms.

Release 11 — 12 months, dose 2

2022-04-08

Symptoms: Possible Pneumonia L Lung, Possible Partially collapsed R Lung under the R Diaphragm L Lower leg infection and significant Swelling/ Triple Antibiotics required

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse reaction · · ✓
SDHeadache ✓ ✓ ✓
SDLocalised infection · · ✓
SDMuscle spasms ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDPeripheral swelling · · ✓
SDSinusitis · · ✓
SDUrinary tract infection ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SROMuscle spasms ✓ ✓ ✓
SROPain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release